Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
(AA - Get Report)
upgraded at BMO from Underperform to Market Perform. $14 price target. Little further share price downside, but company may struggle with profit margins.
(ADBE - Get Report)
downgraded at RBC from Sector Perform to Underperform. $22 price target. New business model could add to near-term sales volatility.
(APOL - Get Report)
rated new Hold at Wunderlich Securities. $49 price target. Current restructuring should benefit the company.
(ARG - Get Report)
upgraded at Goldman from Neutral to Buy. $70 price target. Company has defensive, late-cycle exposure.
Buffalo Wild Wings
upgraded at Sterne Agee from Neutral to Buy. $72 price target. Recent pullback and double digit growth provide an attractive opportunity.
downgraded at JPMorgan from Overweight to Neutral. $170 price target. Weak August USDA data should impact stock.
upgraded at Jefferies from Underperform to Buy. $33 price target. Company has a relatively stable business model.
(CHK - Get Report)
rated new Buy at Brean. $40 price target. Company is growing and working on deleveraging its balance sheet.
upgraded at Stifel from Hold to Buy. $65 price target. Relative risk/reward is attractive at current levels.
downgraded at RBC from Outperform to Underperform. $30 price target. Company's sales tend to tail off in the second half of the year.
upgraded at RBC from Sector Perform to Outperform. $56 price target. Recent deals should add to earnings.
upgraded at RBC from Outperform to Top Pick. $30 price target. Pullback has created an attractive buying opportunity.
upgraded at Citigroup from Hold to Buy. $46 price target. Ad revenues resilient to double dip and EPS upside with buybacks.
(DOW - Get Report)
downgraded at Goldman from Buy to Neutral. $32 price target. Company is likely to see lower demand in the coming quarters.
(DV - Get Report)
estimates, target cut at Morgan Stanley. DV estimates were reduced through 2013. Company is seeing lower new student growth and costs are rising. Overweight rating and new $60 price target.
Devry downgraded at Baird from Outperform to Neutral. $53 price target. Slower economic growth could weigh on sales and margins.